Mileshkin L - Search Results

1

ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy.

Elyashiv O, Ledermann J, Parmar G, Farrelly L, Counsell N, Feeney A, El-Khouly F, Macdonald I, Neto A, Arthur-Darkwa E, Burnett E, Jayson GC, Mileshkin L, Gourley C, Nicum S. Elyashiv O, et al. Among authors: mileshkin l. Int J Gynecol Cancer. 2021 Jan;31(1):134-138. doi: 10.1136/ijgc-2020-002073. Epub 2020 Oct 23. Int J Gynecol Cancer. 2021. PMID: 33097567

2

An analysis of clinical trials assessing the efficacy and safety of single-agent thalidomide in patients with relapsed or refractory multiple myeloma.

Prince HM, Schenkel B, Mileshkin L. Prince HM, et al. Among authors: mileshkin l. Leuk Lymphoma. 2007 Jan;48(1):46-55. doi: 10.1080/10428190601001904. Leuk Lymphoma. 2007. PMID: 17325847

3

Phase 1 study of tirapazamine in combination with radiation and weekly cisplatin in patients with locally advanced cervical cancer.

Rischin D, Narayan K, Oza AM, Mileshkin L, Bernshaw D, Choi J, Hicks R, McClure B, Fyles A. Rischin D, et al. Among authors: mileshkin l. Int J Gynecol Cancer. 2010 Jul;20(5):827-33. doi: 10.1111/IGC.0b013e3181dc827e. Int J Gynecol Cancer. 2010. PMID: 20606530 Clinical Trial.

4

Carboplatin dosing in ovarian cancer: problems and pitfalls.

Collins IM, Roberts-Thomson R, Faulkner D, Rischin D, Friedlander M, Mileshkin L. Collins IM, et al. Among authors: mileshkin l. Int J Gynecol Cancer. 2011 Oct;21(7):1213-8. doi: 10.1097/IGC.0b013e31822127ad. Int J Gynecol Cancer. 2011. PMID: 21705909 Review.

5

Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.

Narayan K, Khaw P, Bernshaw D, Mileshkin L, Kondalsamy-Chennakesavan S. Narayan K, et al. Among authors: mileshkin l. Int J Gynecol Cancer. 2012 Feb;22(2):260-6. doi: 10.1097/IGC.0b013e318230c264. Int J Gynecol Cancer. 2012. PMID: 22080878

6

Oral cyclophosphamide in recurrent ovarian cancer.

Handolias D, Quinn M, Foo S, Mileshkin L, Grant P, Dutu G, Rischin D. Handolias D, et al. Among authors: mileshkin l. Asia Pac J Clin Oncol. 2016 Mar;12(1):e154-60. doi: 10.1111/ajco.12074. Epub 2013 May 29. Asia Pac J Clin Oncol. 2016. PMID: 23718870

7

Patients treated with platinum-doublet chemotherapy for advanced non--small-cell lung cancer have inferior outcomes if previously treated with platinum-based chemoradiation.

Paramanathan A, Solomon B, Collins M, Franco M, Kofoed S, Francis H, Ball D, Mileshkin L. Paramanathan A, et al. Among authors: mileshkin l. Clin Lung Cancer. 2013 Sep;14(5):508-12. doi: 10.1016/j.cllc.2013.03.007. Epub 2013 Jun 20. Clin Lung Cancer. 2013. PMID: 23792009

8

Smokers with cervix cancer have more uterine corpus invasive disease and an increased risk of recurrence after treatment with chemoradiation.

Mileshkin L, Paramanathan A, Kondalsamy-Chennakesavan S, Bernshaw D, Khaw P, Narayan K. Mileshkin L, et al. Int J Gynecol Cancer. 2014 Sep;24(7):1286-91. doi: 10.1097/IGC.0000000000000170. Int J Gynecol Cancer. 2014. PMID: 24987916

9

Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix.

Satoh T, Takei Y, Treilleux I, Devouassoux-Shisheboran M, Ledermann J, Viswanathan AN, Mahner S, Provencher DM, Mileshkin L, Åvall-Lundqvist E, Pautier P, Reed NS, Fujiwara K. Satoh T, et al. Among authors: mileshkin l. Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S102-8. doi: 10.1097/IGC.0000000000000262. Int J Gynecol Cancer. 2014. PMID: 25341572 Review.

10

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas.

Gourley C, Farley J, Provencher DM, Pignata S, Mileshkin L, Harter P, Maenpaa J, Kim JW, Pujaide-Lauraine E, Glasspool RM, Ray-Coquard I, Gershenson D. Gourley C, et al. Among authors: mileshkin l. Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S9-13. doi: 10.1097/IGC.0000000000000257. Int J Gynecol Cancer. 2014. PMID: 25341587 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

281 results

Search Page